VA During, GM Sole, AK Jha, JA Anderson, RT Bryan. Prediction of histological stage based on cystoscopic appearances of newly-diagnosed bladder tumours. Ann R Coll Surg Engl 2016; 98: 547-551.
L Rooshenas, D Elliott, J Wade, M Jepson, S Paramasivan, S Strong, C Wilson, D Beard, JM Blazeby, A Birtle, A Halliday, CA Rogers, R Stein, JL Donovan; ACST-2 study group; By-Band-Sleeve study group; Chemorad study group; CSAW study group; Optima prelim study group; POUT study group. Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials. PLoS Med 2016; 13: e1002147.
JJ D’Costa, JC Goldsmith, JS Wilson, RT Bryan, DG Ward. A systematic review of the diagnostic and prognostic value of urinary protein biomarkers in urothelial bladder cancer. Bladder Cancer 2016; 2: 301-17.
A Feber, P Dhami, L Dong, P de Winter, WS Tan, M Martínez-Fernández, DS Paul, A Hynes-Allen, S Rezaee, P Gurung, S Rodney, Ahmed Mehmood, F Villacampa, F de la Rosa, C Jameson, KK Cheng, MP Zeegers, RT Bryan, ND James, JM Paramio, A Freeman, S Beck, JD Kelly. UroMark - A urinary biomarker assay for the detection of bladder cancer. Clinical Epigenetics 2017; 9: 8-17.
JJ D'Costa, DG Ward, RT Bryan. Urinary biomarkers for the diagnosis of urothelial bladder cancer. New Horizons in Translational Medicine 2016; in press.
DG Ward & RT Bryan. Liquid biopsies for bladder cancer. Translational Andrology & Urology 2017; in press.
FS Togneri, DG Ward, JM Foster, AJ Devall, P Wojtowicz, S Alyas, F Ramos Vasques, A Oumie, ND James, KK Cheng, MP Zeegers, N Deshmukh, B O’Sullivan, P Taniere, KG Spink, DJ McMullan, M Griffiths, RT Bryan. Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA. Eur J Hum Genet 2016 Jan 13. doi: 10.1038/ejhg.2015.281.
DG Ward, L Baxter, N Gordon, S Ott, RS Savage, A Beggs, JD James, J Lickiss, S Green, Y Wallis, W Wei, ND James, MP Zeegers, KK Cheng, GM Mathews, P Patel, M Griffiths, RT Bryan. Multiplex PCR and next generation sequencing for the non-invasive detection of bladder cancer. PLoS One 2016; 11: e0149756.
MO Kitchen, RT Bryan, RD Emes, JR Glossop, C Luscombe, KK Cheng, MP Zeegers, ND James, AJ Devall, CA Mein, L Gommersall, AA Fryer, WE Farrell. Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer. Epigenetics 2016; in press.
MO Kitchen, RT Bryan, KE Haworth, RD Emes, C Luscombe, L Gommersall, KK Cheng, MP Zeegers, ND James, AJ Devall, AA Fryer, WE Farrell. Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer. PLoS One 2015; 10: e0137003.
RT Bryan and DG Ward. Words of Wisdom: Bladder cancers arise from distinct urothelial sub-populations. Eur Urol 2015; 67: 590-1.
RT Bryan, HL Regan, SJ Pirrie, AJ Devall, KK Cheng, MP Zeegers, ND James, MA Knowles, DG Ward. Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM. Br J Cancer 2015; 112: 1052-58.
RT Bryan, NJ Shimwell, W Wei, AJ Devall, S Pirrie, ND James, MP Zeegers, KK Cheng, A Martin, DG Ward. Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential. Br J Cancer 2014; 110: 679-85.
NJ Shimwell, RT Bryan, W Wei, ND James, KK Cheng, MP Zeegers, PJ Johnson, A Martin, DG Ward. Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma. Br J Cancer 2013; 108: 1854-61.
S Naito, F Algaba, M Babjuk, RT Bryan, YH Sun, L Valiquette, J de la Rosette on behalf of the CROES NBI Global Study Group. The Clinical Research Office of the Endourology Society (CROES) multicentre randomised trial of narrow band imaging-assisted transurethral resection (TURBT) versus conventional white light-assisted TURBT in primary non-muscle-invasive bladder cancer patients: trial protocol and 1-year results. Eur Urol 2016; in press.
RT Bryan, LJ Billingham, DMA Wallace. Narrow band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU International 2008; 101: 702-5.
RT Bryan, ZH Shah, SI Collins, DMA Wallace. Narrow band imaging flexible cystoscopy: a new user’s experience. J Endourol 2010; 24: 1339-43.
SC Barnes, DET Shepherd, DM Espino, RT Bryan. Frequency dependent viscoelastic properties of porcine bladder. J Mech Behav Biomed Mater 2014; 42C: 168-76.
SC Barnes, BM Lawless, DET Shepherd, DM Espino, GR Bicknell, RT Bryan. Viscoelastic Properties of Human Bladder Tumours. J Mech Behav Biomed Mater 2016; 61: 250-257.
S Barnes, D Shepherd, D Espino, RT Bryan, R Viney, P Patel. Design of an improved surgical instrument for the removal of bladder tumours. Proc Inst Mech Eng H 2016 Apr 12. pii: 0954411916640580.
X Liu, AC Dowell, P Patel, RP Viney, MC Foster, E Porfiri, ND James, RT Bryan. Cytokines as effectors and predictors of responses in the treatment of bladder cancer by Bacillus Calmette-Guérin. Future Oncol 2014; 10: 1443-56.
AD Bardoli, M Afshar, R Viney, M Foster, E Porfiri, A Zarkar, R Stevenson, ND James, RT Bryan, P Patel. The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic target. Future Oncology 2016; 12: 595-600.
DMA Wallace, RT Bryan, JA Dunn, G Begum, S Bathers. Delay and survival in bladder cancer. BJU International 2002; 89: 868-78.
RT Bryan and DMA Wallace. Have we abandoned the “superficial” in bladder cancer? Eur Urol 2009; 56: 1091.
RT Bryan, SI Collins, MC Daykin, MP Zeegers, KK Cheng, DMA Wallace, GM Sole. Mechanisms of recurrence of Ta/T1 bladder cancer. Ann R Coll Surg Engl 2010; 92: 519-24.
RT Bryan, MP Zeegers, EH van Roekel, D Bird, MR Grant, JA Dunn, S Bathers, G Iqbal, HS Khan, SI Collins, A Howman, NS Deshmukh, ND James, KK Cheng, DMA Wallace. A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years. BJU International 2013; 112: 169-75.
RT Bryan, T Evans, J Dunn, G Iqbal, S Bathers, SI Collins, ND James, JWF Catto, DMA Wallace. A comparative analysis of gender, pathway delays and risk factor exposures on the long-term outcomes from bladder cancer. Eur Urol Focus 2015; 1: 82-89.
EH van Roekel, KK Cheng, ND James, DMA Wallace, LJ Billingham, PG Murray, RT Bryan, MP Zeegers. Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumours at diagnosis. Int J Cancer 2013; 133: 446-54.
FHM van Osch, SHJ Jochems, FJan van Schooten, RT Bryan, MP Zeegers. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies. Int J Epidemiol 2016; in press.
FH van Osch, SH Jochems, FJ van Schooten, RT Bryan, MP Zeegers. Significant role for lifetime cigarette smoking in worsening bladder cancer and upper tract urothelial carcinoma prognosis: a meta-analysis. J Urol 2015 Oct 31. pii: S0022-5347(15)05162-9. doi: 10.1016/j.juro.2015.10.139.
RT Bryan, P Atherfold, Y Yeo, RF Harrison, DMA Wallace, JA Jankowski. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies. J Pathol 2008; 215: 184-194.
RT Bryan. Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena. Philos Trans R Soc Lond B Biol Sci 2015; 370.
All my publications are on PURE, and also here: http://rab.bham.ac.uk/people.asp?uid=cf20c4a8-c59a-45f4-a6e9-e0b6c5ce22b4